[1] 顾菊林,温海,廖万清,等.隐球菌性脑膜炎患者临床免疫指标分析[J].临床皮肤科杂志,2003,32(2):72-73.
[2] 翁心华.隐球菌病[M].秦启贤编.临床真菌学.第1版.上海:复旦大学出版社,2001:346-363.
[3] Koguchi Y,Kawakami K.Cryptococcal infection and Th1-Th2 cytokine balance[J].Int Rev Immunol,2002,21(45):423-438.
[4] Snelgrove RJ,Edwards L,Williams AE,et al.In the absence of reactive oxygen species,T cells default to a Th1 phenotype and mediate protection against pulmonary Cryptococcus neoformans infection[J].J Immunol,2006,177(8):5509-5516.
[5] Kawakami K.Regulation by innate immune T lymphocytes in the host defense against pulmonary infection with Cryptococcus neoformans[J].Jpn J Infect Dis,2004,57(4):137-145.
[6] Stockstill MT,Kaufman CA.Comparison of cryptococcal and tuberculous meningitis[J].Arch Neurol,1983,40(2):81-85.
[7] Sato Y,Osabe S,Kuno H,et al.Rapid diagnosis of cryptococcal meningitis by microscopic examination of centrifuged cerebrospinal fluid sediment[J].J Neurol Sci,1999,164(1):72-75.
[8] Clemons KV,Lutz JE,Stevens DA.Efficacy of recombinant gamma interferon for treatment of systemic cryptococcosis in SCID mice[J].Antimicrob Agents Chemother,2001,45(3):686-689.
[9] Retini C,Kozel TR,Pietrella D,et al.Interdependency of interleukin-10 and interleukin-12 in regulation of T2 cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans[J].Infect Immun,2011,69(10):6064-6073.
[10] Clemons KV,Brummer E,Stevens DA.Cytokine treatment of central nervous system infection:efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis[J].Antimicrob Agents Chemother,1994,38(3):460-464.
[11] Kawakami K,Kinjo Y,Yara,S,et al.Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans[J].Infect Immun,2001,69(1):213-220. |